MyAverix Finance
US · Healthcare
Cellectis SA (CLLS)
Biotechnology
Cellectis SA (CLLS) is listed on US in the Healthcare sector. Industry: Biotechnology. As of 2026-05-23, reported P/E ratio is 25.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for CLLS
Cellectis SA (CLLS) — FAQ
What is CLLS's P/E ratio?
The price-to-earnings (P/E) ratio for Cellectis SA (CLLS) is 25.00 (data as of 2026-05-23).
Does Cellectis SA pay a dividend?
Dividend yield is not available in the current snapshot for Cellectis SA (CLLS). Check the MyAverix Finance app for the latest dividend data.
What sector is Cellectis SA in?
Cellectis SA (CLLS) is classified in the Healthcare sector (Biotechnology industry).
What exchange is CLLS listed on?
CLLS is listed on US.
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.